Chinese Influenza Weekly Report

Similar documents
Chinese Influenza Weekly Report

Chinese Influenza Weekly Report

Chinese Influenza Weekly Report

Chinese Influenza Weekly Report

Chinese Influenza Weekly Report

Chinese Influenza Weekly Report

Influenza Surveillance Summary: Denton County Hospitals and Providers 17.51% 15.95% 10.94% 7.41% 9.01% 8.08%

RESPIRATORY VIRUS SURVEILLANCE REPORT

Surveillance Overview

MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH WEEKLY INFLUENZA UPDATE January 26, 2018

Influenza Global Epidemiologic Update

Seasonal Influenza Report

Influenza Update N 157

Seasonal Influenza Report

Summary. Week 11/2017 (13 19 March 2017) Season overview

Influenza Situation Update

Seasonal Influenza Report

Community and Hospital Surveillance

Influenza Update N 159

Questions and Answers

Influenza Situation Update

Flu Watch. MMWR Week 4: January 21 to January 27, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

Summary. Week 15/2018 (9 15 April 2018) season overview


Influenza Situation Update

GIHSN-China s experience & Results of season Beijing, China

Influenza Situation Update

Influenza Surveillance in Ireland Weekly Report Influenza Week (11 th 17 th December 2017)

Influenza Surveillance in Ireland Weekly Report Influenza Week (22 nd 28 th January 2018)

Summary. Week 13/2018 (26 31 March 2018) season overview

Table 1: Summary of Texas Influenza (Flu) and Influenza-like Illness (ILI) Activity for the Current Week Texas Surveillance Component

Summary. Week 4/2018 (22 28 January 2018) season overview

Influenza Situation Update

Influenza Activity Update

Risk assessment of seasonal influenza - Update, EU/EEA, January 2017

NC IMMUNIZATION COALITION FLU THEN AND NOW NC DHHS COMMUNICABLE DISEASE BRANCH ANITA VALIANI, MPH AUGUST 1, 2018

Bi-weekly Influenza Situation Update

Influenza surveillance summary

Flu Watch. MMWR Week 3: January 14 to January 20, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

Centers for Disease Control and Prevention U.S. INFLUENZA SEASON SUMMARY*

REPORT. Early risk assessment: What to expect of the 2017/18 influenza season in Norway

Week 11: March 11 to March 17, 2018

Week 15: April 8 to April 14, 2018

Influenza Surveillance in Ireland Weekly Report Influenza Week (12 th 18 th March 2018)

Seasonal Influenza Report

Alberta Health. Seasonal Influenza in Alberta. 2016/2017 Season. Analytics and Performance Reporting Branch

Main conclusions and options for response

Seasonal Influenza Report

Influenza Weekly Surveillance Bulletin

Global Influenza Virus Surveillance and WHO Influenza Vaccine Virus Recommendations for the Northern Hemisphere Influenza Season


British Columbia Influenza Surveillance Bulletin Influenza Season , Number 23, Weeks August 13 to September 23, 2017

Influenza Surveillance in Ireland Weekly Report Influenza Weeks 13 & (26 th March 8 th April 2018)

Influenza Prevention Update

Texas Influenza Summary Report, Season (September 28, 2008 April 11, 2009)

British Columbia Influenza Surveillance Bulletin

Influenza Update N 176

Influenza Weekly Surveillance Bulletin

Alberta Health. Seasonal Influenza in Alberta Season. Analytics and Performance Reporting Branch

RAPID RISK ASSESSMENT. Risk assessment of seasonal influenza, EU/EEA, Conclusions and options for response. Update, 25 January 2017

WEEKLY INFLUENZA REPORT

Alberta Health. Seasonal Influenza in Alberta. 2012/2013 Season. Surveillance and Assessment Branch. November Government of Alberta 1

Influenza Weekly Surveillance Bulletin

Weekly Influenza Report

Influenza Situation Update

Summary: Low and Decreasing Activity

Influenza Weekly Surveillance Bulletin

Summary: Increasing Activity

Influenza Weekly Surveillance Bulletin

Incorporating virologic data into seasonal and pandemic influenza vaccines

Weekly Influenza Report

Weekly Influenza Report

Week 11 (Mar.13 19, 2016)

Summary: Sustained Influenza B Activity

Influenza Weekly Surveillance Bulletin

November 5 to 11, 2017 (Week 45)

Manitoba Health, Healthy Living and Seniors (MHHLS) Week 9 (Feb.28 Mar.5, 2016) == Severe outcomes associated with. == Cases and cumulative incidence

Update on Influenza Vaccines, the Influenza Season, and the Impact of Vaccination on Influenza Disease Burden

WEEKLY INFLUENZA REPORT

What to expect of the 2018/19 influenza season in Norway

Influenza Weekly Surveillance Bulletin

MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH WEEKLY INFLUENZA UPDATE January 4, 2019

Summary: Low activity

Manitoba Influenza Surveillance Report

Influenza Activity in Indiana

Western Pacific Regional Office of the World Health Organization.

Western Pacific Regional Office of the World Health Organization

Summary: Low activity

SARI, Influenza and Respiratory Pathogens

MEETING THE STANDARDS: FDA MANDATORY RAPID INFLUENZA DETECTION TEST (RIDTs) RECLASSIFICATION

Influenza Surveillance in Ireland Weekly Report Influenza Week (12 th 18 th November 2018)

WEEKLY INFLUENZA REPORT

Influenza Surveillance in Ireland Weekly Report Influenza Week (1 st 7 th October 2018)

Centers for Disease Control and Prevention U.S. INFLUENZA SEASON SUMMARY*

December 3 to 9, 2017 (Week 49)

INFLUENZA WEEKLY UPDATE 2014/25: June 2014

Influenza and other Respiratory Viruses Update

Influenza Weekly Surveillance Bulletin

Week 43 (Oct , 2016)

Community and Hospital Surveillance

Transcription:

Chinese Influenza Weekly Report (All data are preliminary and may change as more reports are received) Summary During week 13, influenza activity was still a little high in mainland China, and it was increasing in southern China with A(H1N1)pdm09 and B virus epidemic, but declining in northern China with A(H1N1)pdm09 epidemic. Among influenza viruses antigenically characterized by CNIC since September, 2016, 284(100%) influenza A(H1N1)pdm09 viruses were characterized as A/California/7/2009-like; 270(99.6%) influenza A(H1N1)pdm09 viruses were characterized as A/Michigan/45/2015-like; 260(39.0%) influenza A(H3N2) viruses were characterized as A/Hong Kong/4801/2014 (H3N2)(EGG)-like,649(97.3%) influenza A(H3N2) viruses were characterized as A/Hong Kong/4801/2014 (H3N2)(CELL)-like; 184(99.5%) influenza B/Victoria viruses were characterized as B/Brisbane/60/2008-like; 60(92.3%) influenza B/Yamagata viruses were characterized as B/Phuket/3073/2013-like. Among the influenza viruses tested by CNIC for antiviral resistance analysis since September, 2016, all influenza A(H1N1)pdm09 and all influenza A(H3N2) viruses were resistant to adamantine; All influenza A(H1N1)pdm09 and all influenza H3N2 and B viruses were sensitive to neuraminidase inhibitors. 1

Outbreak Surveillance During week 13(Mar 27 th - Apr 2 th, 2017), there were 44 outbreaks reported nationwide, 17 of them were A(H1N1), 7 of them were A(H3N2),14 of them were B,1 of them was negative, 5 of them were untyped. Surveillance of outpatient or emergency visits for Influenza-like Illness (ILI) During week 13, the percentage of outpatient or emergency visits for ILI (ILI %) at national sentinel hospitals in south China was 3.1%, higher than the last week and same week of 2015 (3.0% and 2.8%), lower than the same week of 2016(4.0%). (Figure 1) Figure 1. Percentage of Visits for ILI at Sentinel Hospitals in South China (2012-2017) During week 13, ILI% at national sentinel hospitals in north China was 3.3%, lower than the last week and same week of 2016 (3.4% and 3.7%), higher than the same week of 2015(2.6%). (Figure 2) 2

Figure 2. Percentage of Visits for ILI at Sentinel Hospitals in North China (2012-2017) Virologic Surveillance During week 13, influenza network laboratories tested 7113 specimens, of which 1033(14.5%) were positive for influenza, influenza A and influenza B viruses were 736(71.2%) and 297(28.8%), respectively (Table 1). During week 13, the percentage of specimens that were tested positive for influenza in south China was 15.2%, which was a little higher than the previous week (15.1%) (Figure 3). During week 11, the percentage of specimens that were tested positive for influenza in north China was 13.8%, which was lower than the previous week (15.1%). (Figure 4). Table 1 Laboratory Detections of ILI Specimens (Week 13, 2017) Week 13 South China North China Total No. of specimens tested 3654 3459 7113 No. of positive specimens (%) 555(15.2%) 478(13.8%) 1033(14.5%) Influenza A 276(49.7%) 460(96.2%) 736(71.2%) A(H3N2) 83(30.1%) 56(12.2%) 139(18.9%) A(H1N1)pdm09 191(69.2%) 404(87.8%) 595(80.8%) 3

A (subtype not determined) 2(0.7%) 0 2(0.3%) Influenza B 279(50.3%) 18(3.8%) 297(28.8%) B (lineage not determined) 16(5.7%) 0 16(5.4%) Victoria 234(83.9%) 6(33.3%) 240(80.8%) Yamagata 29(10.4%) 12(66.7%) 41(13.8%) Figure 3. Influenza Positive Tests Reported by Southern Network Laboratories (Week 14, 2015 Week 13, 2017) Note: Analysis in this part was based on the test results of network laboratories. If it were not consistent with the results of CNIC confirmation, the results of CNIC confirmation were used. 4

Figure 4. Influenza Positive Tests Reported by Northern Network Laboratories (Week 14, 2015 Week 13, 2017) Note: Analysis in this part was based on the result of network laboratories. If it were not consistent with the results of CNIC confirmation, the results of CNIC confirmation were used. Antigenic Characterization Since September 1 st, 2016, all of the 284 A(H1N1)pdm09 viruses tested were characterized as A/California/7/2009-like; 270(99.6%) of the 271 A(H1N1)pdm09 viruses tested were characterized as A/Michigan/45/2015-like;260(39.0%) of the 667A(H3N2) influenza viruses tested were characterized as A/Hong Kong/4801/2014 (H3N2)(EGG)-like, 649(97.3%) of the 667 A(H3N2) influenza viruses tested were characterized as A/Hong Kong/4801/2014 (H3N2)(CELL)-like; 184(99.5%) of the 185 influenza B/Victoria lineage viruses tested were characterized as B/Brisbane/60/2008-like; 60(92.3%) of the 65 influenza B/Yamagata lineage viruses tested were characterized as B/Phuket/3073/2013-like. Antiviral Resistance Since September 1 st, 2016, among the influenza viruses tested by CNIC for antiviral resistance, all influenza A(H1N1)pdm09 and all influenza A(H3N2) viruses were resistant to adamantine ; All influenza A(H1N1)pdm09 and all influenza A(H3N2) and B viruses were sensitive to neuraminidase inhibitors. 5